RecruitingNCT04864171

REASSURE-NIRS Registry

REvelation of PAthophySiological PhenotypeS of VUlneRable Lipid-Rich PlaquE on Near-InfraRed Spectroscopy: REASSURE-NIRS

Sponsor

National Cerebral and Cardiovascular Center, Japan

Enrollment

2,000 participants

Start Date

Oct 9, 2018

Study Type

OBSERVATIONAL

Conditions

Lipid-Rich Atherosclerosis of Coronary Artery

Summary

RESSURE-NIRS registry is designed to investigate clinical and pathophysiological characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease. This is an on-going multi-center prospective registry in Japan.

Eligibility

Min Age: 20 YearsMax Age: 95 Years

Inclusion Criteria1

patients with coronary artery disease clinical indication for coronary angiography and/or percutaneous coronary intervention visualization of coronary lesions with NIRS

Exclusion Criteria1

poor quality of NIRS images

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEnear-infrared spectroscopy

Near-infrared spectroscopy is an intravascular imaging device to visualize lipid-rich plaque of coronary artery.

Locations(2)

Miyazaki Medical Association Hospital

Miyazaki, Japan

National Cerebral & Cardiovascular Center

Suita, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04864171

Related Trials

Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

NCT071079711 location